God hasn’t died, it has merely been encapsulated – Psilocybin and ayahuasca in the psychedelic renaissance: Intersections between religion, indigenous cosmologies, spirituality, and science
Social Compass December 1, 2024 DOI: 10.1177/00377686241301923 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Bibliometric analysis Peer reviewed |
|---|---|
| Population | Academic publications on psilocybin and ayahuasca |
| Topics | Ayahuasca Psilocybin |
| Keywords | Secularization Context archaeology Hallucinogen Spirituality Indigenous Social science Anthropology Law |
| Citations | 3 |
| Key points | Psilocybin research is predominantly medical and scientific, while ayahuasca research is more common in the humanities and social sciences, and the two substances are undergoing secularization at different rates. |
Abstract
This article traces the trajectories of psilocybin and ayahuasca in the context of the psychedelic renaissance. The bibliometric analysis reveals that academic publications on psilocybin fall primarily into the medical and scientific areas, whereas those devoted to ayahuasca derive mainly from humanities and social sciences. Second, the article argues that psilocybin and ayahuasca use is undergoing a process of secularization, leading to psychedelic use that is increasingly removed from its traditional cultural roots. This secularization manifests itself differently in the two cases: Psilocybin exhibits a higher degree of secularization than ayahuasca. Ayahuasca maintains strong ties to religious institutions and indigenous organizations deeply involved in its global spread, and it has undergone less medicalization than psilocybin. While the careful attention to setting in psilocybin clinical trials is noteworthy, this doesn’t necessarily imply an emphasis on traditional mushroom use settings. On the other hand, a form of ‘ayahuasca guardianship’ persists, manifested in individuals and groups actively maintaining and asserting their cultural authority over the plant’s significance and associated practices.
Citations in the library
Cited by 3
- The Emergence of Psilocybin in Psychiatry and Neuroscience Pharmaceuticals April 9, 2025
- Ayahuasca revisited. Case studies & observations June 9, 2025
- Psychosis associated with ayahuasca: A narrative review of traditional use, vulnerability, and case evidence Industrial Psychiatry Journal September 25, 2026
Cites 24
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacology & Translational Science December 10, 2020
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Therapeutic Advances in Psychopharmacology March 18, 2016
- Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies CNS Drugs August 17, 2020
and 19 more in the library